相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Investigational HIV integrase inhibitors in phase I and phase II clinical trials
Yingshan Han et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2017)
Accelerating Biomedical Discoveries through Rigor and Transparency
Judith A. Hewitt et al.
ILAR JOURNAL (2017)
Efficient co-delivery of immiscible hydrophilic/hydrophobic chemotherapeutics by lipid emulsions for improved treatment of cancer
Bo Zhang et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)
Doxorubicin delivered by a redox-responsive dasatinib-containing polymeric prodrug carrier for combination therapy
Jingjing Sun et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial
David A. Margolis et al.
LANCET (2017)
Spatial Targeting of Tumor-Associated Macrophages and Tumor Cells with a pH-Sensitive Cluster Nanocarrier for Cancer Chemoimmunotherapy
Song Shen et al.
NANO LETTERS (2017)
cRGD-installed docetaxel-loaded mertansine prodrug micelles: redox-triggered ratiometric dual drug release and targeted synergistic treatment of B16F10 melanoma
Ping Zhong et al.
NANOTECHNOLOGY (2017)
Making individualized drugs a reality (vol 35, pg 507, 2017)
Huub Schellekens et al.
NATURE BIOTECHNOLOGY (2017)
Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia
Andreas Hochhaus et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies
Adam Trickey et al.
LANCET HIV (2017)
Safety and tolerability of long-acting cabotegravir injections in HIV-uninfected men (ECLAIR): a multicentre, double-blind, randomised, placebo-controlled, phase 2a trial
Martin Markowitz et al.
LANCET HIV (2017)
Cancer nanomedicine: progress, challenges and opportunities
Jinjun Shi et al.
NATURE REVIEWS CANCER (2017)
Nanoformulations for combination or cascade anticancer therapy
Lei Miao et al.
ADVANCED DRUG DELIVERY REVIEWS (2017)
Synergistic Cisplatin/Doxorubicin Combination Chemotherapy for Multidrug-Resistant Cancer via Polymeric Nanogels Targeting Delivery
Haiqiu Wu et al.
ACS APPLIED MATERIALS & INTERFACES (2017)
Long-acting combination anti-HIV drug suspension enhances and sustains higher drug levels in lymph node cells than in blood cells and plasma
John C. Kraft et al.
AIDS (2017)
PEGylated lipid bilayer-supported mesoporous silica nanoparticle composite for synergistic co-delivery of axitinib and celastrol in multi-targeted cancer therapy
Ju Yeon Choi et al.
ACTA BIOMATERIALIA (2016)
Strengths, weaknesses, opportunities and challenges for long acting injectable therapies: Insights for applications in HIV therapy
Andrew Owen et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Codelivery of a π-π Stacked Dual Anticancer Drug Combination with Nanocarriers for Overcoming Multidrug Resistance and Tumor Metastasis
Xiao Wei et al.
ADVANCED FUNCTIONAL MATERIALS (2016)
Commentary on Tumor Heterogeneity and the Biology of Cancer Invasion and Metastasis
Isaiah J. Fidler
CANCER RESEARCH (2016)
Development and evaluation of oxaliplatin and irinotecan co-loaded liposomes for enhanced colorectal cancer therapy
Bo Zhang et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Microfluidics: a transformational tool for nanomedicine development and production
Shyam Garg et al.
JOURNAL OF DRUG TARGETING (2016)
Recent Progress on Nanostructures for Drug Delivery Applications
Haijiao Lu et al.
JOURNAL OF NANOMATERIALS (2016)
Using an RNAi Signature Assay To Guide the Design of Three-Drug-Conjugated Nanoparticles with Validated Mechanisms, In Vivo Efficacy, and Low Toxicity
Jonathan C. Barnes et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2016)
Spherical polymeric nanoconstructs for combined chemotherapeutic and anti-inflammatory therapies
Aeju Lee et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2016)
CA4-loaded doxorubicin prodrug coating Fe3O4 nanoparticles for tumor combination therapy
Hongmei Liu et al.
RSC ADVANCES (2016)
Enhanced oral bioavailability of salmeterol by loaded PLGA microspheres: preparation, in vitro, and in vivo evaluation
Haiping Zhang et al.
DRUG DELIVERY (2016)
Anti-HIV Drug-Combination Nanoparticles Enhance Plasma Drug Exposure Duration as Well as Triple-Drug Combination Levels in Cells Within Lymph Nodes and Blood in Primates
Jennifer P. Freeling et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2015)
Telodendrimer nanocarrier for co-delivery of paclitaxel and cisplatin: A synergistic combination nanotherapy for ovarian cancer treatment
Liqiong Cai et al.
BIOMATERIALS (2015)
Targeted delivery of platinum-taxane combination therapy in ovarian cancer
Swapnil S. Desale et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Self-assembled nanoscale coordination polymers carrying oxaliplatin and gemcitabine for synergistic combination therapy of pancreatic cancer
Christopher Poon et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Precision Medicine - Personalized, Problematic, and Promising
J. Larry Jameson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
A New Initiative on Precision Medicine
Francis S. Collins et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
A technology platform to assess multiple cancer agents simultaneously within a patient's tumor
Richard A. Klinghoffer et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Inhibition of P-glycoprotein Gene Expression and Function Enhances Triptolide-induced Hepatotoxicity in Mice
Ling-Lei Kong et al.
SCIENTIFIC REPORTS (2015)
Co-delivery of Cisplatin and Rapamycin for Enhanced Anticancer Therapy through Synergistic Effects and Microenvironment Modulation
Shutao Guo et al.
ACS NANO (2014)
Nanoparticles with Precise Ratiometric Co-Loading and Co-Delivery of Gemcitabine Monophosphate and Cisplatin for Treatment of Bladder Cancer
Lei Miao et al.
ADVANCED FUNCTIONAL MATERIALS (2014)
Long-acting three-drug combination anti-HIV nanoparticles enhance drug exposure in primate plasma and cells within lymph nodes and blood
Jennifer P. Freeling et al.
AIDS (2014)
Anti-tumor efficacy of c(RGDfK)-decorated polypeptide-based micelles co-loaded with docetaxel and cisplatin
Wantong Song et al.
BIOMATERIALS (2014)
Organoid Cultures Derived from Patients with Advanced Prostate Cancer
Dong Gao et al.
CELL (2014)
Pharmacokinetic Enhancers in HIV Therapeutics
Kajal B. Larson et al.
CLINICAL PHARMACOKINETICS (2014)
Nanopharmaceutics: Phytochemical-Based Controlled or Sustained Drug-Delivery Systems for Cancer Treatment
Roubeena Jeetah et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2014)
Therapeutic potential of nanocarrier for overcoming to P-glycoprotein
Vimratjeet Kaur et al.
JOURNAL OF DRUG TARGETING (2014)
Combinational Delivery of Hydrophobic and Hydrophilic Anticancer Drugs in Single Nanoemulsions To Treat MDR in Cancer
Yan Ma et al.
MOLECULAR PHARMACEUTICS (2014)
Colocalized Delivery of Rapamycin and Paclitaxel to Tumors Enhances Synergistic Targeting of the PI3K/Akt/mTOR Pathway
Elvin Blanco et al.
MOLECULAR THERAPY (2014)
Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues
Courtney V. Fletcher et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Anti-HIV drug particles may overcome lymphatic drug insufficiency and associated HIV persistence
Jennifer P. Freeling et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Just caring: Assessing the ethical and economic costs of personalized medicine
Leonard M. Fleck
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2014)
Pharmaceutical nanotechnology for oral delivery of anticancer drugs
Lin Mei et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
pH-sensitive pullulan-based nanoparticle carrier of methotrexate and combretastatin A4 for the combination therapy against hepatocellular carcinoma
Yinsong Wang et al.
BIOMATERIALS (2013)
Genotyping and Genomic Profiling of Non-Small-Cell Lung Cancer: Implications for Current and Future Therapies
Tianhong Li et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Next-Generation Sequencing Reveals High Concordance of Recurrent Somatic Alterations Between Primary Tumor and Metastases From Patients With Non-Small-Cell Lung Cancer
Stephane Vignot et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Combination chemotherapy using core-shell nanoparticles through the self-assembly of HPMA-based copolymers and degradable polyester
Eliezer Jaeger et al.
JOURNAL OF CONTROLLED RELEASE (2013)
The end of AIDS: HIV infection as a chronic disease
Steven G. Deeks et al.
LANCET (2013)
Mutational landscape and significance across 12 major cancer types
Cyriac Kandoth et al.
NATURE (2013)
Combination approaches to combat multidrug-resistant bacteria
Roberta J. Worthington et al.
TRENDS IN BIOTECHNOLOGY (2013)
Cancer drug resistance: an evolving paradigm
Caitriona Holohan et al.
NATURE REVIEWS CANCER (2013)
Modification of physicochemical characteristics of active pharmaceutical ingredients and application of supersaturatable dosage forms for improving bioavailability of poorly absorbed drugs
Kohsaku Kawakami
ADVANCED DRUG DELIVERY REVIEWS (2012)
Nanoparticle-based combination therapy toward overcoming drug resistance in cancer
Che-Ming Jack Hu et al.
BIOCHEMICAL PHARMACOLOGY (2012)
Accelerating Cancer Therapy Development: The Importance of Combination Strategies and Collaboration. Summary of an Institute of Medicine Workshop
Patricia M. LoRusso et al.
CLINICAL CANCER RESEARCH (2012)
Co-delivery of daunomycin and oxaliplatin by biodegradable polymers for safer and more efficacious combination therapy
Haihua Xiao et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Improvement in solubility of poor water-soluble drugs by solid dispersion
Swati Sareen et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICAL INVESTIGATION (2012)
Managing drug resistance in cancer: lessons from HIV therapy
Christoph Bock et al.
NATURE REVIEWS CANCER (2012)
Mechanisms of drug resistance in kinases
Rina Barouch-Bentov et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2011)
The seed and soil hypothesis revisited-The role of tumor-stroma interactions in metastasis to different organs
Robert R. Langley et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Pharmacokinetics and biodistribution of lonidamine/paclitaxel loaded, EGFR-targeted nanoparticles in an orthotopic animal model of multi-drug resistant breast cancer
Lara Milane et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2011)
Nanoparticulate Delivery System Targeted to Tumor Neovasculature for Combined Anticancer and Antiangiogenesis Therapy
Zhe Wang et al.
PHARMACEUTICAL RESEARCH (2011)
A nanocapsular combinatorial sequential drug delivery system for antiangiogenesis and anticancer activities
Zhe Wang et al.
BIOMATERIALS (2010)
Use of nanoscale delivery systems to maintain synergistic drug ratios in vivo
Awa Dicko et al.
EXPERT OPINION ON DRUG DELIVERY (2010)
Biomedical Informatics in the Education of Physicians
Edward H. Shortliffe
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Genome remodelling in a basal-like breast cancer metastasis and xenograft
Li Ding et al.
NATURE (2010)
Origins and Evolution of Antibiotic Resistance
Julian Davies et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2010)
Simultaneous delivery of doxorubicin and gemcitabine to tumors in vivo using prototypic polymeric drug carriers
Twan Lammers et al.
BIOMATERIALS (2009)
Safety, Pharmacokinetics, and Efficacy of CPX-1 Liposome Injection in Patients with Advanced Solid Tumors
Gerald Batist et al.
CLINICAL CANCER RESEARCH (2009)
Nanoparticle-based targeted drug delivery
Rajesh Singh et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2009)
Personalized Cancer Therapy With Selective Kinase Inhibitors: An Emerging Paradigm in Medical Oncology
Ultan McDermott et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Modulation of drug resistance in ovarian adenocarcinoma by enhancing intracellular ceramide using tamoxifen-loaded biodegradable polymeric nanoparticles
Harikrishna Devalapally et al.
CLINICAL CANCER RESEARCH (2008)
Identification of genotype-correlated sensitivity to selective kinase inhibitors by using high-throughput tumor cell line profiling
Ultan McDermott et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Ratiometric dosing of anticancer drug combinations: Controlling drug ratios after systemic administration regulates therapeutic activity in tumor-bearing mice
Lawrence D. Mayer et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system
S Sengupta et al.
NATURE (2005)
Role of nanotechnology in targeted drug delivery and imaging: a concise review
Otilia M. Koo et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2005)
Evaluation of combination chemotherapy: Integration of nonlinear regression, curve shift, isobologram, and combination index analyses
L Zhao et al.
CLINICAL CANCER RESEARCH (2004)
Lipid-drug association enhanced HIV-1 protease inhibitor indinavir localization in lymphoid tissues and viral load reduction: A proof of concept study in HIV-2(287)-infected macaques
L Kinman et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2003)
Pharmacokinetics of pegylated liposomal doxorubicin - Review of animal and human studies
A Gabizon et al.
CLINICAL PHARMACOKINETICS (2003)
Pegylated liposomal doxorubicin: Metamorphosis of an old drug into a new form of chemotherapy
AA Gabizon
CANCER INVESTIGATION (2001)
分享论文
